119 related articles for article (PubMed ID: 10480232)
1. Ion-exchange chromatography separation of the detergent and the solvent from immunoglobulins after solvent-detergent treatment.
Gebauer B; Simić M; Branović K; Trescec A; Benko B
J Chromatogr A; 1999 Aug; 852(1):83-6. PubMed ID: 10480232
[TBL] [Abstract][Full Text] [Related]
2. Removal of detergent and solvent from solvent-detergent-treated immunoglobulins.
Trescec A; Simić M; Branović K; Gebauer B; Benko B
J Chromatogr A; 1999 Aug; 852(1):87-91. PubMed ID: 10480233
[TBL] [Abstract][Full Text] [Related]
3. Virus reduction in an intravenous immunoglobulin by solvent/detergent treatment, ion-exchange chromatography and terminal low pH incubation.
Roberts PL; Dunkerley C; Walker C
Biologicals; 2012 Sep; 40(5):345-52. PubMed ID: 22658506
[TBL] [Abstract][Full Text] [Related]
4. Extraction of Triton X-100 and its determination in virus-inactivated human plasma by the solvent--detergent method.
Strancar A; Raspor P; Schwinn H; Schütz R; Josic D
J Chromatogr A; 1994 Jan; 658(2):475-81. PubMed ID: 8118553
[TBL] [Abstract][Full Text] [Related]
5. A chromatographic method for the production of a human immunoglobulin G solution for intravenous use.
Tanaka K; Sawatani E; Shigueoka EM; Campos TC; Nakao HC; Dias GA; Fujita RK; Arashiro F
Braz J Med Biol Res; 1998 Nov; 31(11):1375-81. PubMed ID: 9921271
[TBL] [Abstract][Full Text] [Related]
6. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.
Korneyeva M; Hotta J; Lebing W; Rosenthal RS; Franks L; Petteway SR
Biologicals; 2002 Jun; 30(2):153-62. PubMed ID: 12127317
[TBL] [Abstract][Full Text] [Related]
7. Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies.
Dichtelmüller HO; Biesert L; Fabbrizzi F; Gajardo R; Gröner A; von Hoegen I; Jorquera JI; Kempf C; Kreil TR; Pifat D; Osheroff W; Poelsler G
Transfusion; 2009 Sep; 49(9):1931-43. PubMed ID: 19497061
[TBL] [Abstract][Full Text] [Related]
8. Solvent/detergent-treated plasma: a tale of 30 years of experience.
Liumbruno GM; Marano G; Grazzini G; Capuzzo E; Franchini M
Expert Rev Hematol; 2015 Jun; 8(3):367-74. PubMed ID: 25695198
[TBL] [Abstract][Full Text] [Related]
9. Convenient and rapid removal of detergent from glycolipids in detergent-resistant membrane microdomains.
Suzuki Y; Kabayama K
J Lipid Res; 2012 Mar; 53(3):599-608. PubMed ID: 22217704
[TBL] [Abstract][Full Text] [Related]
10. Comparable virus inactivation by bovine or vegetable derived Tween 80 during solvent/detergent treatment.
Seitz H; Blümel J; Schmidt I; Willkommen H; Löwer J
Biologicals; 2002 Sep; 30(3):197-205. PubMed ID: 12217344
[TBL] [Abstract][Full Text] [Related]
11. A chromatographically purified human TGF-β1 fraction from virally inactivated platelet lysates.
Burnouf T; Chang CW; Kuo YP; Wu YW; Tseng YH; Su CY
Vox Sang; 2011 Oct; 101(3):215-20. PubMed ID: 21521235
[TBL] [Abstract][Full Text] [Related]
12. Comparative removal of solvent and detergent viral inactivating agents from human intravenous immunoglobulin G preparations using SDR HyperD and C18 sorbents.
Burnouf T; Sayed MA; Radosevich M; El-Ekiaby M
Anal Biochem; 2009 Jun; 389(1):69-73. PubMed ID: 19303391
[TBL] [Abstract][Full Text] [Related]
13. [Purification of immunoglobulin and serum albumin from serum via strong anion exchange chromatography coupled with molecular exclusion chromatography].
Qin Z; Chen T; Li R
Se Pu; 2012 Aug; 30(8):851-5. PubMed ID: 23256392
[TBL] [Abstract][Full Text] [Related]
14. Human platelet concentrates: a source of solvent/detergent-treated highly enriched brain-derived neurotrophic factor.
Burnouf T; Kuo YP; Blum D; Burnouf S; Su CY
Transfusion; 2012 Aug; 52(8):1721-8. PubMed ID: 22211513
[TBL] [Abstract][Full Text] [Related]
15. [Chromatographic support to remove solvent/detergent mixture utilized as viral attenuation agent].
Guerrier L; Flayeux I; Boschetti E
Ann Pharm Fr; 1996; 54(3):97-102. PubMed ID: 8794577
[TBL] [Abstract][Full Text] [Related]
16. Manufacture and in vitro characterization of a solvent/detergent-treated human plasma.
Hellstern P; Sachse H; Schwinn H; Oberfrank K
Vox Sang; 1992; 63(3):178-85. PubMed ID: 1448962
[TBL] [Abstract][Full Text] [Related]
17. Physico-chemical and biological properties of solvent/detergent treated immunoglobuin G preparations.
Nesterova NV; Kurkina OV; Samoilenko VA; Skrynnyk MM
Mikrobiol Z; 2009; 71(6):35-42. PubMed ID: 20455431
[TBL] [Abstract][Full Text] [Related]
18. Preparation, purification and virus inactivation of intravenous immunoglobulin from human plasma.
Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Banazadeh S
Hum Antibodies; 2010; 19(1):1-6. PubMed ID: 20555125
[TBL] [Abstract][Full Text] [Related]
19. Progress in purification of virus-inactivated factor VIII concentrates. Three generations of solvent/detergent treated plasma derivatives.
Schwinn H; Smith A; Wolter D
Arzneimittelforschung; 1989 Oct; 39(10):1302-5. PubMed ID: 2514695
[TBL] [Abstract][Full Text] [Related]
20. Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII.
Roberts PL
Biologicals; 2008 Sep; 36(5):330-5. PubMed ID: 18674928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
